TickerKhojComparison · NSE · data 2026-11-02
Gujarat Themis Biosyn Ltd vs Evonile Pharma Limited
In plain words
Size: Gujarat Themis Biosyn Ltd is about 1.1 times the market value of Evonile Pharma Limited.
Valuation (P/E): Gujarat Themis Biosyn Ltd 83.8 vs Evonile Pharma Limited 44.5.
Return on equity: Gujarat Themis Biosyn Ltd 17.4% vs Evonile Pharma Limited 11.6%.
Profit growth over 3 years: Evonile Pharma Limited -3.4% a year vs Gujarat Themis Biosyn Ltd -7% a year.
Debt to equity: Gujarat Themis Biosyn Ltd 0.56 vs Evonile Pharma Limited 0.
Differences in the numbers, not a recommendation of either stock.
Side by side
| GUJTHEM | NOVARTIND | |
|---|---|---|
| Price | ₹374.3 | ₹1,763.8 |
| Market cap | ₹4,718 cr | ₹4,182 cr |
| P/E | 83.8 | 44.5 |
| P/B | — | — |
| ROE | 17.4% | 11.6% |
| ROCE | 18.2% | 11.8% |
| Debt / equity | 0.56 | 0 |
| Operating margin | 38.9% | 27.0% |
| Dividend yield | 0.18% | 1.48% |
| Sales growth, 3 years (yearly) | 3.8% | -2.2% |
| Profit growth, 3 years (yearly) | -7.0% | -3.4% |
| 1-year return | -19.9% | 155.2% |
| Revenue, last 12 months | ₹174 cr | ₹371 cr |
| Net profit, last 12 months | ₹49 cr | ₹98 cr |
| Latest quarter | Jun 2026 | — |
| Quarter net profit | ₹11 cr | — |
| Quarter profit vs a year earlier | +22.2% | — |
| Promoter holding | 59.33% | — |
| Health check | Weak (3.8/10) | Average (5.6/10) |
Common questions
Which has a higher P/E, Gujarat Themis Biosyn Ltd or Evonile Pharma Limited?
Gujarat Themis Biosyn Ltd trades at the higher P/E (83.8 against 44.5). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Gujarat Themis Biosyn Ltd (17.4% against 11.6%).
Which carries more debt?
Gujarat Themis Biosyn Ltd has the higher debt-to-equity ratio (0.56 against 0).